We are live on ! Find out more
CDIOW icon

Cardio Diagnostics Holdings Inc Warrant

10 hedge funds and large institutions have $254K invested in Cardio Diagnostics Holdings Inc Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $226K → $254K (+$28.3K)

0% more funds holding

Funds holding: 1010 (0)

1.12% less ownership

Funds ownership: 1.12%0% (-1.1%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

CDIOW Hedge Fund Activity: Q3 2025 in Review

10 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics Holdings Inc Warrant (CDIOW) for Q3 2025, worth a combined $254K — up 13% from $226K a quarter earlier.

Fund positioning in CDIOW was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $645. The largest seller was UBS Group, cutting an estimated $13.

  • 10 institutional investors held Cardio Diagnostics Holdings Inc Warrant (CDIOW) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $254K of Cardio Diagnostics Holdings Inc Warrant stock for Q3 2025, up 13% quarter-over-quarter.
  • 0 funds opened new Cardio Diagnostics Holdings Inc Warrant positions in Q3 2025 and 0 closed out.
  • The largest Cardio Diagnostics Holdings Inc Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $645 added.
  • The largest Cardio Diagnostics Holdings Inc Warrant seller in Q3 2025 was UBS Group, an estimated $13 sold.

Based on aggregated 13F filings for Q3 2025.